Skip to main content
Journal cover image

NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report.

Publication ,  Journal Article
Shulman, HM; Cardona, DM; Greenson, JK; Hingorani, S; Horn, T; Huber, E; Kreft, A; Longerich, T; Morton, T; Myerson, D; Prieto, VG; Ziemer, M ...
Published in: Biol Blood Marrow Transplant
April 2015

The 2005 National Institute of Health (NIH) Consensus Conference outlined histopathological diagnostic criteria for the major organ systems affected by both acute and chronic graft-versus-host disease (GVHD). The 2014 Consensus Conference led to this updated document with new information from histopathological studies of GVHD in the gut, liver, skin, and oral mucosa and an expanded discussion of GVHD in the lungs and kidneys. The recommendations for final histological diagnostic categories have been simplified from 4 categories to 3: no GVHD, possible GVHD, and likely GVHD, based on better reproducibility achieved by combining the previous categories of "consistent with GVHD" and "definite GVHD" into the single category of "likely GVHD." Issues remain in the histopathological characterization of GVHD, particularly with respect to the threshold of histological changes required for diagnostic certainty. Guidance is provided for the incorporation of biopsy information into prospective clinical studies of GVHD, particularly with respect to biomarker validation.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Biol Blood Marrow Transplant

DOI

EISSN

1523-6536

Publication Date

April 2015

Volume

21

Issue

4

Start / End Page

589 / 603

Location

United States

Related Subject Headings

  • Skin Diseases
  • Mouth Diseases
  • Male
  • Liver Diseases
  • Intestinal Diseases
  • Immunology
  • Humans
  • Graft vs Host Disease
  • Female
  • Clinical Trials as Topic
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Shulman, H. M., Cardona, D. M., Greenson, J. K., Hingorani, S., Horn, T., Huber, E., … Kleiner, D. E. (2015). NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report. Biol Blood Marrow Transplant, 21(4), 589–603. https://doi.org/10.1016/j.bbmt.2014.12.031
Shulman, Howard M., Diana M. Cardona, Joel K. Greenson, Sangeeta Hingorani, Thomas Horn, Elisabeth Huber, Andreas Kreft, et al. “NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report.Biol Blood Marrow Transplant 21, no. 4 (April 2015): 589–603. https://doi.org/10.1016/j.bbmt.2014.12.031.
Shulman HM, Cardona DM, Greenson JK, Hingorani S, Horn T, Huber E, et al. NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report. Biol Blood Marrow Transplant. 2015 Apr;21(4):589–603.
Shulman, Howard M., et al. “NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report.Biol Blood Marrow Transplant, vol. 21, no. 4, Apr. 2015, pp. 589–603. Pubmed, doi:10.1016/j.bbmt.2014.12.031.
Shulman HM, Cardona DM, Greenson JK, Hingorani S, Horn T, Huber E, Kreft A, Longerich T, Morton T, Myerson D, Prieto VG, Rosenberg A, Treister N, Washington K, Ziemer M, Pavletic SZ, Lee SJ, Flowers MED, Schultz KR, Jagasia M, Martin PJ, Vogelsang GB, Kleiner DE. NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report. Biol Blood Marrow Transplant. 2015 Apr;21(4):589–603.
Journal cover image

Published In

Biol Blood Marrow Transplant

DOI

EISSN

1523-6536

Publication Date

April 2015

Volume

21

Issue

4

Start / End Page

589 / 603

Location

United States

Related Subject Headings

  • Skin Diseases
  • Mouth Diseases
  • Male
  • Liver Diseases
  • Intestinal Diseases
  • Immunology
  • Humans
  • Graft vs Host Disease
  • Female
  • Clinical Trials as Topic